NorthStar Healthcare Income(NHHS)
$1.900.00 (0.00%)
NHHS
NorthStar Healthcare Income financials statements
$1.90
At close:0.00 (0.00%)
NorthStar Healthcare Income (NHHS) Ratios
7 Followers
NorthStar Healthcare Income Ratios
NHHS's free cash flow for Q1 2025 was $7.26M. For the 2025 fiscal year, NHHS's free cash flow was decreased by $-1.52M and operating cash flow was $7.26M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.06 | 3.77 | 5.27 | 6.47 | 1.37 |
| Quick Ratio | 10.06 | 3.77 | 5.30 | 6.47 | 1.37 |
| Cash Ratio | 7.31 | 3.02 | 4.62 | 6.04 | 0.77 |
| Solvency Ratio | 0.15 | -0.13 | -0.02 | 0.08 | -0.13 |
| Operating Cash Flow Ratio | 0.56 | 0.68 | 0.35 | -0.19 | 0.36 |
| Short-Term Operating Cash Flow Coverage | 0.30 | 0.15 | 0.17 | -0.01 | 0.89 |
| Net Current Asset Value | $ -471.55M | $ -821.63M | $ -818.29M | $ -751.45M | $ -1.39B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.76 | 0.85 | 0.74 | 0.66 | 0.76 |
| Debt-to-Equity Ratio | 3.71 | 6.76 | 3.05 | 2.09 | 3.54 |
| Debt-to-Capital Ratio | 0.79 | 0.87 | 0.75 | 0.68 | 0.78 |
| Long-Term Debt-to-Capital Ratio | 0.79 | 0.87 | 0.75 | 0.68 | 0.78 |
| Financial Leverage Ratio | 4.89 | 7.97 | 4.14 | 3.18 | 4.68 |
| Debt Service Coverage Ratio | 0.43 | 0.28 | 0.30 | 0.04 | 0.36 |
| Interest Coverage Ratio | 0.39 | 0.24 | 1.69 | 1.01 | 0.56 |
| Debt to Market Cap | 5.30 | 9.16 | 5.61 | 7.46 | 4.91 |
| Interest Debt Per Share | 4.89 | 4.99 | 4.92 | 5.17 | 8.01 |
| Net Debt to EBITDA | 9.77 | 16.31 | 29.47 | 16.57 | 37.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 99.65% | 12.61% | 21.34% | 22.33% | 28.86% |
| EBIT Margin | 9.55% | 5.54% | -6.03% | -4.10% | -9.99% |
| EBITDA Margin | 26.97% | 24.33% | 14.81% | 16.69% | 12.98% |
| Operating Profit Margin | 9.55% | 5.87% | 39.53% | 23.52% | 12.98% |
| Pretax Profit Margin | 47.27% | -78.14% | -29.41% | 10.20% | -93.34% |
| Net Profit Margin | 47.42% | -76.54% | -29.22% | 9.50% | -92.38% |
| Continuous Operations Profit Margin | 47.23% | -78.18% | -29.44% | 10.17% | -93.36% |
| Net Income Per EBT | 100.32% | 97.95% | 99.38% | 93.14% | 98.97% |
| EBT Per EBIT | 494.74% | -1330.58% | -74.38% | 43.37% | -719.30% |
| Return on Assets (ROA) | 8.67% | -14.81% | -4.37% | 1.77% | -13.63% |
| Return on Equity (ROE) | 42.40% | -118.06% | -18.09% | 5.64% | -63.83% |
| Return on Capital Employed (ROCE) | 1.82% | 1.17% | 6.02% | 4.50% | 2.00% |
| Return on Invested Capital (ROIC) | 1.69% | 1.04% | 5.80% | 2.68% | 1.97% |
| Return on Tangible Assets | 8.67% | -14.84% | -4.38% | 1.78% | -13.82% |
| Earnings Yield | 55.54% | -139.99% | -31.63% | 10.06% | -88.41% |
| Efficiency Ratios | |||||
| Receivables Turnover | 137.04 | 131.56 | 65.77 | 71.95 | 19.21 |
| Payables Turnover | 0.02 | 6.51 | 6.92 | 7.66 | 5.24 |
| Inventory Turnover | 0.00 | 0.00 | -208.05 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.20 | 0.27 | 0.19 |
| Asset Turnover | 0.18 | 0.19 | 0.15 | 0.19 | 0.15 |
| Working Capital Turnover Ratio | 0.89 | 2.36 | 1.33 | 2.48 | 7.87 |
| Cash Conversion Cycle | -21315.13 | -53.27 | -48.92 | -42.56 | -50.60 |
| Days of Sales Outstanding | 2.66 | 2.77 | 5.55 | 5.07 | 19.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | -1.75 | 0.00 | 0.00 |
| Days of Payables Outstanding | 21317.80 | 56.04 | 52.72 | 47.63 | 69.60 |
| Operating Cycle | 2.66 | 2.77 | 3.80 | 5.07 | 19.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.13 | 0.10 | 0.04 | -0.03 | 0.16 |
| Free Cash Flow Per Share | 0.04 | -0.10 | -0.11 | -0.18 | 0.08 |
| Dividend Paid and CapEx Coverage Ratio | 1.50 | 0.50 | 0.06 | -0.23 | 2.04 |
| Capital Expenditure Coverage Ratio | 1.50 | 0.50 | 0.27 | -0.23 | 2.04 |
| Operating Cash Flow Coverage Ratio | 0.03 | 0.02 | 0.01 | -0.01 | 0.02 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.09 | 0.04 | -0.02 | 0.11 |
| Free Cash Flow Yield | 4.54% | -17.28% | -12.56% | -13.73% | 5.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 1.79 | -0.71 | -3.16 | 9.94 | -1.13 |
| Price-to-Sales (P/S) Ratio | 0.85 | 0.55 | 0.92 | 0.94 | 1.04 |
| Price-to-Book (P/B) Ratio | 0.76 | 0.84 | 0.57 | 0.56 | 0.72 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 22.02 | -5.79 | -7.96 | -7.28 | 18.71 |
| Price-to-Operating Cash Flow Ratio | 7.35 | 5.88 | 21.86 | -38.70 | 9.53 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | -0.00 | 0.01 | -0.09 | -0.00 |
| Enterprise Value Multiple | 12.93 | 18.55 | 35.71 | 22.23 | 45.79 |
| Enterprise Value | 720.73M | 925.18M | 979.34M | 978.46M | 1.68B |
| EV to EBITDA | 12.93 | 18.55 | 35.71 | 22.23 | 45.79 |
| EV to Sales | 3.49 | 4.51 | 5.29 | 3.71 | 5.94 |
| EV to Free Cash Flow | 89.96 | -47.79 | -45.59 | -28.60 | 106.40 |
| EV to Operating Cash Flow | 30.04 | 48.54 | 125.17 | -151.98 | 54.21 |
| Tangible Book Value Per Share | 1.23 | 0.68 | 1.54 | 2.32 | 2.03 |
| Shareholders’ Equity Per Share | 1.24 | 0.70 | 1.54 | 2.32 | 2.16 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Revenue Per Share | 1.11 | 1.08 | 0.95 | 1.38 | 1.49 |
| Net Income Per Share | 0.53 | -0.83 | -0.28 | 0.13 | -1.38 |
| Tax Burden | 1.00 | 0.98 | 0.99 | 0.93 | 0.99 |
| Interest Burden | 4.95 | -14.11 | 4.88 | -2.49 | 9.34 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.06 | 0.07 | 0.08 | 0.05 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.25 | -0.12 | -0.14 | -0.24 | -0.12 |
Currency in USD
